The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1

Alzheimer’s disease (AD) represents a progressive amyloidogenic disorder whose advancement is widely recognized to be connected to amyloid-β peptides and Tau aggregation. However, several other processes likely contribute to the development of AD and some of them might be related to protein-protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciccone, Lidia, Shi, Chenghui, di Lorenzo, Davide, Van Baelen, Anne-Cécile, Tonali, Nicolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288020/
https://www.ncbi.nlm.nih.gov/pubmed/32456156
http://dx.doi.org/10.3390/molecules25102439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288020/
https://www.ncbi.nlm.nih.gov/pubmed/32456156
http://dx.doi.org/10.3390/molecules25102439

Ejemplares similares